Introduction

This page provides a comprehensive analysis of the known insider trading history of Mark Sumeray. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate Mark Sumeray has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:AEGR / Aegerion Pharmaceuticals, Inc. Chief Medical Officer 40,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Mark Sumeray. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by Mark Sumeray as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2015-08-06 2015-08-04 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 40,000 40,000
2015-04-03 2015-04-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 10,000 10,000
2015-04-03 2015-04-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 40,000 40,000
2015-01-05 2014-12-31 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 65,000 65,000
2014-04-21 2014-04-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 20,000 20,000
2014-03-18 2014-03-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 113,000 -1.74
2014-03-18 2014-03-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -800 0 -100.00 51.98 -41,584
2014-03-18 2014-03-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -900 800 -52.94 51.31 -46,179 41,048
2014-03-18 2014-03-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -300 1,700 -15.00 49.69 -14,907 84,473
2014-03-18 2014-03-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2014-02-18 2014-02-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 115,000 -1.71
2014-02-18 2014-02-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 0 -100.00 64.52 -32,260
2014-02-18 2014-02-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,500 500 -75.00 63.14 -94,710 31,570
2014-02-18 2014-02-14 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2014-01-21 2014-01-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 117,000 -1.68
2014-01-21 2014-01-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 0 -100.00 59.51 -5,951
2014-01-21 2014-01-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,900 100 -95.00 58.59 -111,318 5,859
2014-01-21 2014-01-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2014-01-06 2014-01-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -1,000 119,000 -0.83
2014-01-06 2014-01-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 0 -100.00 71.41 -42,847
2014-01-06 2014-01-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -400 600 -40.00 70.22 -28,087 42,130
2014-01-06 2014-01-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 1,000 1,000 13.01 13,010 13,010
2013-12-17 2013-12-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 120,000 -1.64
2013-12-17 2013-12-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -200 0 -100.00 67.38 -13,476
2013-12-17 2013-12-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,800 200 -90.00 66.23 -119,211 13,246
2013-12-17 2013-12-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2013-12-04 2013-12-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -3,000 122,000 -2.40
2013-12-04 2013-12-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 0 -100.00 71.20 -42,718
2013-12-04 2013-12-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,400 600 -80.00 70.23 -168,549 42,137
2013-12-04 2013-12-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 3,000 3,000 13.01 39,030 39,030
2013-11-19 2013-11-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 125,000 -1.57
2013-11-19 2013-11-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 0 -100.00 77.63 -38,817
2013-11-19 2013-11-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,011 500 -66.91 75.89 -76,726 37,945
2013-11-19 2013-11-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -489 1,511 -24.45 74.93 -36,639 113,215
2013-11-19 2013-11-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2013-11-05 2013-11-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -3,500 127,000 -2.68
2013-11-05 2013-11-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 0 -100.00 84.34 -8,434
2013-11-05 2013-11-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,000 100 -95.24 83.59 -167,180 8,359
2013-11-05 2013-11-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,400 2,100 -40.00 82.76 -115,867 173,800
2013-11-05 2013-11-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 3,500 3,500 13.01 45,535 45,535
2013-10-16 2013-10-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 130,500 -1.51
2013-10-16 2013-10-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,000 0 -100.00 80.71 -80,709
2013-10-16 2013-10-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,000 1,000 -50.00 79.95 -79,950 79,950
2013-10-16 2013-10-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2013-10-08 2013-10-07 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -3,500 132,500 -2.57
2013-10-08 2013-10-07 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -700 0 -100.00 94.81 -66,368
2013-10-08 2013-10-07 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,265 700 -64.38 93.23 -117,932 65,259
2013-10-08 2013-10-07 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,535 1,965 -43.86 92.37 -141,786 181,505
2013-10-08 2013-10-07 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 3,500 3,500 13.01 45,535 45,535
2013-09-18 2013-09-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 136,000 -1.45
2013-09-18 2013-09-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 0 -100.00 92.51 -9,251
2013-09-18 2013-09-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -800 100 -88.89 90.41 -72,330 9,041
2013-09-18 2013-09-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 900 -35.71 89.73 -44,867 80,761
2013-09-18 2013-09-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -600 1,400 -30.00 88.50 -53,101 123,902
2013-09-18 2013-09-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2013-08-20 2013-08-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise -2,000 138,000 -1.43
2013-08-20 2013-08-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -400 0 -100.00 90.08 -36,033
2013-08-20 2013-08-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -700 400 -63.64 88.81 -62,168 35,524
2013-08-20 2013-08-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -900 1,100 -45.00 88.01 -79,212 96,814
2013-08-20 2013-08-16 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2013-07-16 2013-07-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise 2,000 140,000 1.45
2013-07-16 2013-07-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -742 0 -100.00 79.60 -59,063
2013-07-16 2013-07-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -758 742 -50.53 78.95 -59,841 58,577
2013-07-16 2013-07-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -500 1,500 -25.00 77.28 -38,642 115,926
2013-07-16 2013-07-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 2,000 2,000 13.01 26,020 26,020
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise 6,000 142,000 4.41
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -100 0 -100.00 68.44 -6,844
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,400 100 -93.33 67.73 -94,828 6,773
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -900 1,500 -37.50 66.67 -60,007 100,012
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,000 2,400 -29.41 65.36 -65,364 156,874
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -791 3,400 -18.87 63.86 -50,517 217,138
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -1,809 4,191 -30.15 63.05 -114,060 264,248
2013-06-19 2013-06-17 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 6,000 6,000 13.01 78,060 78,060
2013-05-17 2013-05-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise 6,000 148,000 4.23
2013-05-17 2013-05-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -6,000 0 -100.00 47.32 -283,930
2013-05-17 2013-05-15 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 6,000 6,000 13.01 78,060 78,060
2013-04-24 2013-04-22 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		M - Exercise 6,000 154,000 4.05
2013-04-24 2013-04-22 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -2,150 0 -100.00 41.36 -88,923
2013-04-24 2013-04-22 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		S - Sale X -3,850 2,150 -64.17 40.40 -155,528 86,853
2013-04-24 2013-04-22 4 AEGR Aegerion Pharmaceuticals, Inc.
Common Stock 		M - Exercise 6,000 6,000 13.01 78,060 78,060
2013-04-03 2013-04-01 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 27,500 27,500
2013-01-04 2013-01-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		A - Award 20,000 20,000
2013-01-04 2013-01-02 4 AEGR Aegerion Pharmaceuticals, Inc.
Stock Option (right to buy) 		D - Sale to Issuer -20,000 0 -100.00
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)